Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
The Witcher director Marc Jobst explains why he believes Henry Cavill quit as the fantasy series' lead
Ice Cube's response to Elon Musk's meme about him has Internet saying he 'roasted him hard'
How to unblock YouTube Premium
Your mental health internet search may lead to malware
Get lifetime access to this all-in-one AI productivity tool for under £40
SEC sues Coinbase, Binance crypto exchanges, alleging sale of unregistered securities
Roomba, Shark, or Roborock? The Best Pre-Prime Day Robot Vacuum Deals
How to unblock Tapmad for free